检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:任新玲[1] 钱桂生[1] 鲍炜[2] 付海京[3] 贾林涛[3] 张瑞[3] 王涛[3] 许彦鸣[3] 杨安钢[2]
机构地区:[1]第三军医大学新桥医院全军呼吸病研究所,重庆400037 [2]第四军医大学基础部免疫学教研室,陕西西安710033 [3]第四军医大学生物化学与分子生物学教研室,陕西西安710033
出 处:《第四军医大学学报》2006年第9期828-831,共4页Journal of the Fourth Military Medical University
基 金:国家重大基础研究计划项目"973"(2004CB518805);教育部"长江学者和创新团队发展计划"项目(IRT0459)
摘 要:目的:构建针对HER2/neu的RNA干涉载体,观察对HER2/neu表达抑制及抑制后对非小细胞肺癌生长的影响.方法:设计和合成长度为64nt的脱氧寡核苷酸链,退火互补成双链,克隆至pSUPER质粒载体,转化DH5α菌株,提取质粒,转染过表达HER2/neu的肺腺癌细胞系SPCA1,RTPCR检测HER2/neu的mRNA表达,Westernblot和间接免疫荧光法检测HER2/neu的蛋白表达,FCM分析细胞周期变化,MTT法观察细胞生长.结果:肺腺癌细胞系SPCA1存在HER2/neu过表达;成功构建了HER2/neu特异性RNA干涉载体pSUPERsiHER2;瞬时转染SPCA1细胞,HER2/neu的mRNA及蛋白表达均降低;G1期细胞较亲代增加9.9%;肿瘤细胞增殖速度减慢(P<0.05).结论:成功构建了HER2/neuRNA干涉载体,转染后可有效降低肺腺癌细胞系SPCA1HER2/neu的mRNA转录及蛋白水平表达,阻滞转染细胞于G1期,造成转染细胞生长速度减慢,这有望为肺癌基因治疗提供一种选择手段.AIM: To construct RNA interference (RNAi) vector to down-regulate HER2/neu gene and study the RNAi effect on the cell cycle and tumor growth of non-small cell lung cancer. METHODS: Oligonucleotides of 64 base pairs for hairpin RNA targeting HER2/neu were designed, chemically synthesized and annealed, and cloned into pSUPER vector. After identified by restriction digestion, the right vectors were transiently transfected into SPC-A-1 cells, a human lung adenocarcinoma cell line. The HER2 mRNA was detected by RT-PCR, and the protein detected by Western blot and indirect immunolluorescence staining. FCM analysis and MTT method were applied to measure cell cycle and cell growth respectively. RESULTS: SPC-A-1 cells had an overexpression of HER2. The vector of RNAi which can interfere HER2/neu gene was successfully constructed, and compared with parent cells, the vector can increase the number of cells in G0/GI phase by 9.9%, and inhibit the tumor cell growth ( P 〈 0.05 ). CONCLUSION: We successfully constructed an expressing hairpin RNA against HER2/neu vector. The vector can effectively silence HER2/neu gene, increase the number of cells in G0/GI phase, and then slow down the growth of tumor cells. This may be a useful therapeutic strategy for NSCLC over-expressing HER2/ neu.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.78